The DOI matches its Crossref record.
Oral vaccination of mice against tetanus with recombinant Lactococcus lactis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 25
- Wells, J.M. and Schofield, K.M. 1996. pp. 37–62 in Lactic Acid Bacteria: Current Advances in Metabolism, Genetics and Applications. NATO ASI Series vol H98. Bozoglu, T.F. and Ray, B. (eds.) Springer-Verlag, Berlin. · doi:10.1007/978-3-642-61462-0_3
- Newby, T.J. and Stokes, C.R. 1984. The intestinal immune system and oral vaccination. Vet. Immunol. Immunopathol. 6: 67–105. · DOI
- McGhee, J.M., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M., and Kiyono, H. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10: 75–88. · DOI · Paper page
- Gruzza, M., Duval-Iflah, Y., and Ducluzeau, R. 1992. Colonisation of the digestive tract of germfree mice by genetically engineered strains of Lactococcus lactis: study of recombinant DNA stability. Microb. Releases 1: 165–171.
- Wells, J.M., Norton, P.M., and Le Page, R.W.F. 1995. Progress in the development of mucosal vaccines based on Lactococcus lactis. Int. Dairy J. 5: 1071–1079. · DOI
- Challacombe, S.J., 1983. Salivary antibodies and systemic tolerance in mice after oral immunization with bacterial antigens. Ann. N.Y. Acad. Sci. 409: 177–192. · doi:10.1111/j.1749-6632.1983.tb26868.x
- Wold, A.E., Dahlgren, U.I.H., Hanson, L.A., Mattsby-Baltzer, I., and Midvetdt, T. 1989. Difference between bacterial and food antigens in mucosal immunogenicity. Infect Immun. 57: 2666–2673. · DOI
- Challacombe, S.J., Rahman, D., Jeffery H., Davis, S.S., and O'Hagan, D.T., 1992. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76: 164–168.
- Marteau, P., and Rambaud, J.-C. 1993. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol. Revs. 12: 207–220. · doi:10.1111/j.1574-6976.1993.tb00019.x · Paper page
- Di Tommaso, A., de Magistris, M.T., Bugnoli, M., Rappuoli, R., and Abrignani, S 1994. Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen presentation. Infect. Immun. 62: 1830–1834. · doi:10.1128/iai.62.5.1830-1834.1994
- Cryz, S.J., Furer, E., and Germanier, R. 1982. Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholere. Infect. Immun. 38: 21–26. · doi:10.1128/iai.38.1.21-26.1982
- Eisenberg, G.H.G. and Osterman, J.V. 1977.Experimental scrub typhus immunogens: gamma-irradiated and formalinised rickettsie. Infect. Immun. 15: 124–131. · doi:10.1128/iai.15.1.124-131.1977
- Bachmann, M.F., Kundig, T.M., Kalberer, C.P., Hengartner, H., and Zinkernagel, R.M. 1993. Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-Help- independent B-cell responses. J. Virol. 67: 3917–3922. · DOI
- Tarkkanen, J., Saksela, E., and Lanier, L.L 1986. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. J. Immunol. 137: 2428–2433. · DOI
- Fairweather, N.F., Lyness, V.A., and Maskell, D.J. 1987. Immunization of mice against tetanus with fragments of tetanus toxin synthesised in Escherichia coli. Infect. Immun. 55: 2541–2545. · doi:10.1128/iai.55.11.2541-2545.1987
- Wells, J.M., Wilson, P.W., Norton, P.M., Gasson, M.J., and Le Page, R.W.F. 1993. Lactococcus lactis : high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol. Microbiol. 8: 1155–1162. · DOI · Paper page
- Hohmann, A., Schmidt, G., and Rowley, D. 1979. Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coil and Salmonella-Escherichia coli hybrid strains. Infect. Immun. 25: 27–33. · doi:10.1128/iai.25.1.27-33.1979
- VanCott, J.L., Staats, H.F., Pascual, D.W., Roberts, M., Chatfield, S.N., Yamamoto, M., et al. 1996. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156: 1504–1514. · doi:10.4049/jimmunol.156.4.1504
- Chamberlain, L.M., Robinson, K., Wells, J.M., and Le Page, R.W.F 1995. Immunogenicity of glutathione S-transferase (P28) from Schistosoma mansoni expressed in Lactococcus lactis. Immunology 86 (suppl. 1):139.
- Balloul, J.-M., Grzych, J.-M., Pierce, R.J., and Capron, A. A., 1987. Purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J. Immunol. 138: 3448–3453. · doi:10.4049/jimmunol.138.10.3448
- Lagranderie, M., Murray, A., Gicquel, B., Leclerc, C., and Gheorghiu, M. 1993. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine. 11: 1283–1290. · doi:10.1016/0264-410x(93)90096-g
- Medaglini, D., Pozzi, G., King, T.P., and Fischetti, V.A. 1995. Mucosal and systemic responses to a recombinant protein expressed on the surface of the oral commensal Streptococcus gordonii after oral colonisation. Proc. Natl. Adac. Sci. USA 92: 6868–6872. · DOI · Paper page
- Gasson, M.J. 1983. Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast induced curing. J. Bacteriol. 154: 1–9. · DOI · Paper page
- Wells, J.M., Wilson, P.W., and Le Page, R.W.F. 1993. Improved cloning vectors and transformation procedure for Lactococcus lactis. J. Appl. Bacteriol. 74: 629–636. · DOI · Paper page
- Norton, P.M., Brown, H.W.G., and Le Page, R.W.F. 1994. The immune response to Lactococcus lactis : Implications for its use as a vaccine delivery vehicle. FEMS Microbiol. Letts. 120: 249–256. · DOI
Cited by
The use of bacterial spore formers as probiotics: Table 1
Hong, H. A., Duc, L. H., & Cutting, S. M. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.001 · Cited by 975
Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria
Wells, J. M., & Mercenier, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1840 · Cited by 537
Self-citationFermented functional foods based on probiotics and their biogenic metabolites
Stanton, C., Ross, R. P., Fitzgerald, G. F., & Sinderen, D. V. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.02.008 · Cited by 496
Lactic Acid Bacteria As Live Vaccines
(2000) · Current Issues in Molecular Biology · doi:10.21775/cimb.002.017 · Cited by 193
Systems Solutions by Lactic Acid Bacteria: From Paradigms to Practice
de Vos, W. M. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-s1-s2 · Cited by 134
Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations
Ramasamy, R., Yasawardena, S., Zomer, A., Venema, G., Kok, J., & Leenhouts, K. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.040 · Cited by 102
Anchoring of proteins to lactic acid bacteria
Leenhouts, K., Buist, G., & Kok, J. (1999) · Antonie van Leeuwenhoek · doi:10.1023/a:1002095802571 · Cited by 97
Chatel, J.-M., Langella, P., Adel-Patient, K., Commissaire, J., Wal, J.-M., & Corthier, G. (2001) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.3.545-551.2001 · Cited by 89
Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle
SCHEPPLER, L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00229-3 · Cited by 77
Germond, J.-E., Delley, M., Gilbert, C., & Atlan, D. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.6.3377-3384.2003 · Cited by 36
Bernasconi, E., Germond, J.-E., Delley, M., Fritsché, R., & Corthésy, B. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.6.2917-2923.2002 · Cited by 21
Metadata
- Authors
- Robinson, K., Chamberlain, L. M., Schofield, K. M., Wells, J. M., & Le Page, R. W. F.
- Venue
- Nature Biotechnology
- Published
- 1997-07-01
- Volume
- 15
- Issue
- 7
- Pages
- 653-657
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2025022796
- Cited by
- 250
- References
- 0
- FWCI
- 17.56
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.